Last Month In Digital Health (June 2025)

CONTENTS: 1) 💊Pharma Digital Health | 2)📲Digital Therapeutics | 3) 🤖Health Tech 4)⌚️Wearables & Sensors | 5) 🧠 Artificial Intelligence | 6)💰Funding & Finance

1)💊 Pharma Digital Health

🔘 Sanofi and Regeneron have partnered with Viz.ai to deploy an AI-powered platform for earlier detection and management of COPD, aiming to improve outcomes through smarter triage and care coordination. The collaboration applies natural language processing to EHR data to flag high-risk patients and expand access to timely treatment

🔘 AstraZeneca has partnered with Aptar Digital Health to develop AI tools that detect early signs of chronic kidney disease through retinal scans. The collaboration aims to support earlier diagnosis during routine eye exams and aligns with AZ’s broader strategy to integrate digital tools into CKD care

🔘 Boehringer Ingelheim has partnered with Tempus AI in a multi-year deal to enhance its oncology pipeline using real-world data and AI-powered analytics. The collaboration gives Boehringer access to over 8 million patient records and advanced tools to accelerate cancer research and personalize treatment development

🔘 Boehringer Ingelheim has partnered with Datavant to securely integrate real-world patient data into over 75 clinical trials, aiming to accelerate development and tailor treatments more precisely. The partnership enables data linkage without moving or exposing raw health records, preserving privacy while unlocking valuable insights

🔘 Abbott is integrating glucose data from its FreeStyle Libre system into Epic’s EHR, allowing seamless access to patient trends within clinical workflows. The move streamlines diabetes management for providers and reflects a broader push to embed wearable data directly into everyday healthcare decisions

🔘 Moderna is expanding its partnership with Benchling to roll out a digital R&D platform across its entire research organization, aiming to streamline data management and accelerate scientific workflows. The platform will replace legacy tools and support AI-driven experiment design, sample tracking, and data analysis

🔘 Merck Healthcare and Dawn Health have launched a digital ecosystem for growth hormone deficiency, combining child-friendly features, caregiver tools, and real-time clinical insights. The platform sets the stage for AI-driven growth predictions and personalized treatment, reflecting Merck’s broader push to embed digital infrastructure in long-term care

🔘 Takeda partners with Salesforce to deploy its Life Sciences Cloud, using AI-powered tools to enhance engagement across medical, commercial, and patient support teams. This move marks a shift away from longtime CRM provider Veeva

🔘 Johnson & Johnson MedTech has partnered with Qure.ai to enhance early detection of lung cancer in India by deploying AI-powered screening at new Incidental Pulmonary Nodule clinics. The initiative will use X-ray and CT scan analysis across 30 medical centers to identify lung nodules at earlier, more treatable stages

2)📲Digital Therapeutics

🔘 H2O Therapeutics’ Parky app is now EU-approved for clinical use in Parkinson’s, joining its earlier FDA clearance. By turning the Apple Watch into a passive symptom tracker, Parky helps bridge the gap between clinic visits and real-life care with continuous, personalized monitoring

🔘 The NHS has conditionally approved ORBIT, a digital CBT program for young people with Tourette syndrome and chronic tic disorders, making it the first NICE-backed digital therapy for these conditions. Delivered online with e-coach support, ORBIT showed strong trial results and will now be rolled out while real-world data is gathered to guide wider adoption

🔘 Nerva has acquired key assets from Mahana Therapeutics to strengthen its leadership in digital gut-brain therapies for IBS. By integrating Mahana’s CBT content into its platform, Nerva aims to expand access to gold-standard, evidence-based care at scale, without the bottlenecks of in-person GI psychology

🔘 The Access to Prescription Digital Therapeutics Act has been reintroduced in Congress to create a Medicare benefit category for FDA-cleared software-based treatments. Backed by new cost data from Germany and growing bipartisan interest, advocates see a rare window to expand access and unlock broader reimbursement for digital therapeutics

🔘 Omada Health is aiming for a $1.1 billion valuation with its planned IPO on the Nasdaq, offering 7.9 million shares at $18 to $20 each. The target valuation aligns with its last private funding round in 2022, as the company expands its virtual care model across diabetes, hypertension, musculoskeletal care, and more

🔘 Hinge Health closed its IPO 17% above its listing price, but still at a $3 billion valuation, less than half its $6.2 billion valuation in 2021

3)🤖Health Tech

🔘 The FDA has cleared the first blood test to aid in Alzheimer’s diagnosis for adults over 55 with cognitive symptoms, offering a faster and less invasive alternative to PET scans or spinal taps. Developed by Fujirebio, the test detects key biomarkers linked to amyloid buildup and could help improve early access to treatments like Leqembi and Kisunla

🔘 Neuralink's first human trial participant, a man with ALS, is now able to communicate using only his thoughts thanks to a brain implant that translates neural signals into digital commands. The device has restored his ability to speak, type, and interact with others, offering a powerful glimpse into the potential of brain-computer interfaces to restore independence

🔘 Apple is teaming up with Synchron to let users control devices with their thoughts. What starts as an accessibility breakthrough could become the next evolution in how we interact with technology

🔘 Researchers have 3D-bioprinted living pancreatic-like tissue entirely from collagen, using a technique that mimics real blood vessels at high resolution. The breakthrough could transform diabetes treatment by creating implantable tissue capable of producing insulin in response to glucose

🔘 German Bionic has launched Exia, an AI-powered exoskeleton that learns from its wearer and adapts in real time to support movement. While its current focus is industry, the potential applications in healthcare and mobility support are extensive

🔘 And it's happening, researchers are developing MyoStep, a soft, lightweight exoskeleton designed to help children with cerebral palsy walk more easily. Using smart fabrics, artificial muscles, and real-time sensors, it adapts to each child’s movements, and even grows with them

🔘 Scientists have created contact lenses that give humans the ability to see near-infrared light, adding a whole new layer to how we experience the world. It’s an early step, but one that hints at a future where wearable tech doesn’t just restore function, it expands it.

4)⌚️Wearables & Sensors

🔘 ZEM Life is developing a smartwatch that doesn’t just detect potential fentanyl overdoses, it can automatically inject Narcan if the user doesn’t respond. Using existing sensors to track vitals and movement, the device aims to intervene in real time and may eventually expand to other emergencies like asthma or heart attacks

🔘 Ōura, Google Fitbit, and academic partners are testing whether wearables and smartphones can help predict and prevent opioid relapse. By combining data on sleep, stress, isolation, and mood, the pilot aims to build a real-time early warning system for one of America’s deadliest public health crises

🔘 Oura Ring now syncs with Dexcom’s Stelo CGM, giving users personalized glucose and meal insights powered by AI. The integration brings real-time metabolic tracking to non-insulin users through a seamless wearable experience.

🔘 A new AI-powered chip could detect heart attacks in real time, showing a 92.4% accuracy in lab tests, fast enough to save lives by spotting cardiac events as they happen, not after. Designed to run on wearables, it could bring emergency-level diagnostics straight to the wrist

🔘 AI-powered insoles can now predict ground reaction forces with just 4.1% error, making it possible to measure how your body interacts with the ground in real-world settings. This breakthrough could transform sports training, rehab, and diabetic care by spotting harmful pressure patterns and improving movement efficiency

5) 🧠 Artificial Intelligence Highlights

>> Here is a snapshot of some key developments, but see this month's AI newsletter - coming soon - for more in-depth coverage

🔘 SpotitEarly is bringing its AI-and-dog-powered cancer breath test to the U.S., offering a non-invasive, high-accuracy alternative to traditional screenings. The at-home test detects VOCs using trained dogs and AI, with over 94% accuracy in early-stage cancer detection.

🔘 An AI model called FaceAge can estimate biological age from a photo and may help predict cancer survival, with patients who appear older than their actual age showing worse outcomes. Tested on thousands of cancer cases, the tool outperformed doctors in forecasting survival, raising both clinical potential and ethical questions about how appearance could shape care decisions

🔘 NICE has conditionally approved Skin Analytics' AI tool, DERM, to help the NHS triage suspected skin cancers, aiming to reduce unnecessary referrals without compromising safety. Using smartphone-captured images, DERM analyzes skin lesions to flag high-risk cases and reassure low-risk ones, marking the first AI of its kind to be eligible for core NHS funding

🔘 Foresight a generative AI model trained on health data from 57 million people in England, is aiming to predict disease risk and support earlier, more personalised NHS care. Developed by UCL and King’s College London, it's one of the first AI tools trained at national scale on real-world NHS data and could help reduce emergency hospitalisations through smarter prevention

6)💰Funding & Finance

🔘 Hims & Hers raises $1B

🔘 Neuralink raises $600M at a $9B valuation

🔘 Pathos AI raises $365M for AI oncology drug development

🔘 Persivia secures $107M to expand AI-driven healthcare platform

🔘 Cohere Health lands $90M Series C to expand AI use cases

🔘 Akido Labs secures $60M to expand AI-powered ScopeAI

🔘 Sprinter Health raises $55M to expand its at-home healthcare service

🔘 DarioHealth announces $50M in debt financing

🔘 PhaseV secures $50M for AI clinical development

🔘 TSOLife raises $43M to expand AI in senior living

🔘 Phase Scientific completes $34M Series A for urine-based diagnostics

🔘 Dazos raises $25M for healthcare CRM platform

🔘 Carta Healthcare raises $18.25M to expand AI clinical data platform

🔘 Chipiron raises $17M for miniature MRI prototype

🔘 Dawn Health secures $13M for global expansion

🔘 Persist AI secures $12M Series A for Cloud Lab platform

🔘 AssistIQ raises $11.5M for AI-enabled supply tracking

🔘 Ontrak secures $10M for AI-enabled behavioral healthcare engagement

🔘 Geviti closes $8.5M seed round for longevity healthcare

🔘 Rad AI raises additional $8M for generative AI in radiology

🔘 Brooklyn Health scores $6.5M for mental health assessment in trials

🔘 MedIQ raises $6M Series A for Middle East expansion

🔘 Epicore Biosystems secures $6M for sweat-sensing wearables

🔘 Kindbridge Behavioral Health raises $5.4M for digital mental health platform

🔘 WellTheory raises $5M for AI-enabled autoimmune care

🔘 Pluto Bio raises $3.6M for AI-powered multi-omics platform

🔘 Mentaily secures $3M for AI-powered mental health tool

🔘 ReportAId raises €2.2M using AI to unlock healthcare data